Skip to main content
. Author manuscript; available in PMC: 2024 Aug 28.
Published in final edited form as: J Am Vet Med Assoc. 2020 Jan 1;256(1):66–76. doi: 10.2460/javma.256.1.66

Table 1—

Number of terrestrial mammal specimens submitted to public health laboratories for RABV testing, number of RABV-positive specimens, and number of specimens that underwent RABV characterization in the United States by year during the period of January 2010 through December 2015.

Year
Variable 2010 2011 2012 2013 2014 2015 Mean (95% CI)
No. of specimens tested 81,278 77,644 76,379 71,041 74,615 72,717 75,612 (71,768–79,456)
No. of RABV-positive specimens (%) 4,723 (5.8) 4,650 (6.0) 4,488 (5.9) 4,288 (6.0) 4,277 (5.7) 3,804 (5.2) 4,371 (4,022–4,720)
No. of RABV-positive specimens that underwent virus characterization (%) 1,341 (28.4) 1,728 (37.2) 1,257 (28.0) 1,227 (28.6) 1,209 (28.3) 1,116 (29.3) 1,315 (1,089–1,542)

Rabies surveillance data for terrestrial nonvolant mammals (excluding humans) in the United States that were submitted to the CDC during the period of January 2010 through December 2015 were included in this evaluation. Bat data were not included but underwent separate analysis.20